Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$21,473,821
+$8,264,540 QoQ
Shares Held
891,770
+89.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#274
of 2,821 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2025CallValue
$249,000
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Concurrent Investment Advisors, LLC holds $273,585,885 across 14 Drug Manufacturers - General names. PFE ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
232,761 | $59,114,311 | |
| 2 | LLY |
ELI LILLY & Co
|
46,836 | $56,176,507 | |
| 3 | ABBV |
AbbVie Inc.
|
160,023 | $40,268,187 | |
| 4 | MRK |
Merck & Co., Inc.
|
280,871 | $36,091,923 | |
| 5 | PFE |
Pfizer Inc
This page
|
891,770 | $21,473,821 | |
| 6 | AMGN |
Amgen Inc
|
51,650 | $18,703,497 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
266,252 | $15,341,440 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
81,664 | $10,317,429 |
All Filings in PFE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,473,821 | 891,770 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $13,209,281 | 470,416 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $249,000 | 10,000 | Call | Sole | 2026-01-29 | |
| 2025-12-31 | $10,749,827 | 431,720 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $76,440 | 3,000 | Put | Sole | 2025-10-27 | |
| 2025-09-30 | $5,403,671 | 212,075 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $4,866,786 | 200,775 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $4,564,038 | 180,112 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $4,000,458 | 150,790 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $4,363,081 | 150,763 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $4,359,955 | 155,824 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,457,956 | 88,575 | Shares | Sole | 2024-05-07 | |
| 2024-03-31 | $138,750 | 5,000 | Call | Sole | 2024-05-07 | |
| 2023-12-31 | $3,536,851 | 122,850 | Shares | Sole | 2024-04-15 | |
| No filing history on record for this holder in this stock. | ||||||